Similarly, follow up on the anti-TB treatment showed that patients who had significant reduction in TB load showed a shift from CD4+IFN-γ+ TEMRA cells to CD4+IFN-γ+IL-2+ TEM (Caccamo et al., 2010). This evidence concerns the gene IL2 and tuberculosis.